vs
Pulmonx Corp(LUNG)与REDWOOD TRUST INC(RWT)财务数据对比。点击上方公司名可切换其他公司
REDWOOD TRUST INC的季度营收约是Pulmonx Corp的1.3倍($25.9M vs $20.6M),REDWOOD TRUST INC净利率更高(77.2% vs -66.3%,领先143.6%),REDWOOD TRUST INC同比增速更快(-6.1% vs -8.7%),过去两年Pulmonx Corp的营收复合增速更高(-0.5% vs -41.0%)
Pulmonx Corp是一家主营介入肺病学医疗解决方案的全球医疗科技企业,主打用于治疗慢性阻塞性肺疾病、肺气肿的微创支气管内瓣膜产品,业务覆盖北美、欧洲、亚太等市场,为重症肺病患者提供低创伤治疗选择。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司,主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理,核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务,客户以机构投资者和房地产市场参与者为主。
LUNG vs RWT — 直观对比
营收规模更大
RWT
是对方的1.3倍
$20.6M
营收增速更快
RWT
高出2.6%
-8.7%
净利率更高
RWT
高出143.6%
-66.3%
两年增速更快
LUNG
近两年复合增速
-41.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $20.6M | $25.9M |
| 净利润 | $-13.7M | $20.0M |
| 毛利率 | 77.9% | — |
| 营业利润率 | -40.9% | — |
| 净利率 | -66.3% | 77.2% |
| 营收同比 | -8.7% | -6.1% |
| 净利润同比 | 5.5% | 402.6% |
| 每股收益(稀释后) | $-0.33 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LUNG
RWT
| Q1 26 | $20.6M | — | ||
| Q4 25 | $22.6M | $25.9M | ||
| Q3 25 | $21.5M | $15.0M | ||
| Q2 25 | $23.9M | $13.8M | ||
| Q1 25 | $22.5M | $27.9M | ||
| Q4 24 | $23.8M | $27.6M | ||
| Q3 24 | $20.4M | $25.5M | ||
| Q2 24 | $20.8M | $67.4M |
净利润
LUNG
RWT
| Q1 26 | $-13.7M | — | ||
| Q4 25 | $-10.4M | $20.0M | ||
| Q3 25 | $-14.0M | $-7.7M | ||
| Q2 25 | $-15.2M | $-98.5M | ||
| Q1 25 | $-14.4M | $16.1M | ||
| Q4 24 | $-13.2M | $-6.6M | ||
| Q3 24 | $-14.1M | $14.8M | ||
| Q2 24 | $-15.3M | $15.5M |
毛利率
LUNG
RWT
| Q1 26 | 77.9% | — | ||
| Q4 25 | 77.6% | — | ||
| Q3 25 | 74.7% | — | ||
| Q2 25 | 72.1% | — | ||
| Q1 25 | 72.5% | — | ||
| Q4 24 | 74.0% | — | ||
| Q3 24 | 73.7% | — | ||
| Q2 24 | 73.7% | — |
营业利润率
LUNG
RWT
| Q1 26 | -40.9% | — | ||
| Q4 25 | -43.8% | — | ||
| Q3 25 | -66.9% | -9.0% | ||
| Q2 25 | -62.0% | -679.0% | ||
| Q1 25 | -64.6% | 80.2% | ||
| Q4 24 | -56.5% | -1.3% | ||
| Q3 24 | -69.3% | 86.1% | ||
| Q2 24 | -75.2% | 30.3% |
净利率
LUNG
RWT
| Q1 26 | -66.3% | — | ||
| Q4 25 | -46.1% | 77.2% | ||
| Q3 25 | -64.9% | -51.4% | ||
| Q2 25 | -63.6% | -712.0% | ||
| Q1 25 | -64.1% | 57.8% | ||
| Q4 24 | -55.4% | -24.0% | ||
| Q3 24 | -69.4% | 58.1% | ||
| Q2 24 | -73.7% | 23.0% |
每股收益(稀释后)
LUNG
RWT
| Q1 26 | $-0.33 | — | ||
| Q4 25 | $-0.25 | $0.11 | ||
| Q3 25 | $-0.34 | $-0.08 | ||
| Q2 25 | $-0.38 | $-0.76 | ||
| Q1 25 | $-0.36 | $0.10 | ||
| Q4 24 | $-0.33 | $-0.08 | ||
| Q3 24 | $-0.36 | $0.09 | ||
| Q2 24 | $-0.39 | $0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $61.6M | $255.7M |
| 总债务越低越好 | $37.3M | — |
| 股东权益账面价值 | $45.8M | $982.6M |
| 总资产 | $120.0M | $23.7B |
| 负债/权益比越低杠杆越低 | 0.82× | — |
8季度趋势,按日历期对齐
现金及短期投资
LUNG
RWT
| Q1 26 | $61.6M | — | ||
| Q4 25 | $69.8M | $255.7M | ||
| Q3 25 | $76.5M | $226.3M | ||
| Q2 25 | $75.5M | $302.0M | ||
| Q1 25 | $74.6M | $259.9M | ||
| Q4 24 | $70.9M | $245.2M | ||
| Q3 24 | $63.3M | $253.7M | ||
| Q2 24 | $63.5M | $275.6M |
总债务
LUNG
RWT
| Q1 26 | $37.3M | — | ||
| Q4 25 | $37.1M | — | ||
| Q3 25 | $37.1M | — | ||
| Q2 25 | $37.1M | — | ||
| Q1 25 | $37.2M | — | ||
| Q4 24 | $37.2M | — | ||
| Q3 24 | $37.2M | — | ||
| Q2 24 | $37.2M | — |
股东权益
LUNG
RWT
| Q1 26 | $45.8M | — | ||
| Q4 25 | $54.1M | $982.6M | ||
| Q3 25 | $60.0M | $999.0M | ||
| Q2 25 | $69.1M | $1.1B | ||
| Q1 25 | $77.7M | $1.2B | ||
| Q4 24 | $85.8M | $1.2B | ||
| Q3 24 | $93.9M | $1.2B | ||
| Q2 24 | $101.2M | $1.2B |
总资产
LUNG
RWT
| Q1 26 | $120.0M | — | ||
| Q4 25 | $129.3M | $23.7B | ||
| Q3 25 | $138.3M | $22.6B | ||
| Q2 25 | $147.2M | $21.3B | ||
| Q1 25 | $150.7M | $19.9B | ||
| Q4 24 | $162.8M | $18.3B | ||
| Q3 24 | $167.4M | $18.4B | ||
| Q2 24 | $172.6M | $16.5B |
负债/权益比
LUNG
RWT
| Q1 26 | 0.82× | — | ||
| Q4 25 | 0.69× | — | ||
| Q3 25 | 0.62× | — | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.43× | — | ||
| Q3 24 | 0.40× | — | ||
| Q2 24 | 0.37× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
LUNG
RWT
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | $-10.1B | ||
| Q3 25 | $-8.2M | $-2.7B | ||
| Q2 25 | $-3.9M | $-2.1B | ||
| Q1 25 | $-13.2M | $-2.0B | ||
| Q4 24 | $-6.7M | $-5.9B | ||
| Q3 24 | $-7.2M | $-2.1B | ||
| Q2 24 | $-5.8M | $-2.0B |
自由现金流
LUNG
RWT
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | — | ||
| Q3 25 | $-8.3M | — | ||
| Q2 25 | $-4.0M | — | ||
| Q1 25 | $-13.5M | — | ||
| Q4 24 | $-6.8M | — | ||
| Q3 24 | $-7.7M | — | ||
| Q2 24 | $-6.2M | — |
自由现金流率
LUNG
RWT
| Q1 26 | — | — | ||
| Q4 25 | -31.4% | — | ||
| Q3 25 | -38.4% | — | ||
| Q2 25 | -16.6% | — | ||
| Q1 25 | -60.0% | — | ||
| Q4 24 | -28.8% | — | ||
| Q3 24 | -37.6% | — | ||
| Q2 24 | -30.0% | — |
资本支出强度
LUNG
RWT
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — |
现金转化率
LUNG
RWT
| Q1 26 | — | — | ||
| Q4 25 | — | -504.15× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -140.86× | ||
| Q2 24 | — | -126.56× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图